Steven Joel Feigenberg, MD

Radiation Oncology
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman-Concourse Level
Headshot of Steven Joel Feigenberg, MD
Penn Medicine Provider

About me

  • Chief, Thoracic Service, Radiation Oncology
  • Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Temple University Hospital
  • Residency: Rutgers University-New Brunswick

Spoken languages

English
English

Reviews

Average Rating

210 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
July 2026
i have confidence in their professional knowledge and respect for patients
Anonymous
July 2026
my appointment was for 9:15 but didn't see dr feirgenburg until 10:00 am. my time is just as valuable as the doctor's time
Anonymous
July 2026
i will travel for the care given
Anonymous
June 2026
he's very informative and nice

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Feigenberg is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Feigenberg S, Friedes C, Bradley J Caution Against Uncritical Adoption of Neoadjuvant Chemoimmunotherapy Followed by Definitive Radiotherapy in Stages II to III NSCLC: In Response to Adib et al , JTO Clinical and Research Reports, 7: 2026


Ehsan Ranjbar 1, Thomas Werner 1, Steven Feigenberg 2, Abass Alavi 3 Role of PET in Radiation Oncology: A Theranostic Perspective on Detection of Radiation-Induced Complications , PET Clin .: 2026


Zheng Zhang 1, Sang Ho Lee 2, Rich Caruana 3 4, Harsha Nori 3, Yong Fan 5, Xingmei Wang 6, Nikhil Yegya-Raman 2, Charles B Simone 2nd 7 8, Gary D Kao 2, Steven J Feigenberg 2, Ying Xiao 2 Hypothesis Generation via Interpretable Machine Learning: A Case Study on Risk Factors for Postradiation Therapy Lung Cancer Recurrence , Adv Radiat Oncol .: 2026


Ivy S. Han BS a, , Kyunga Ko MS a b c, , Jennifer Wei Zou PhD c d, , Amanda M. Smith MA a c, , Nikhil Yegya-Raman MD c d, , Amber Daniels BS, RDCS a c, , Carla Triolo MS, PA-C c, , Congying Xia MD, PhD a c, , Raymond H. Mak MD e, , Christian Guthier PhD e, , Gerard Walls FRCR, PhD f g, , Clifford Robinson MD f h, , Michael Soike MD i, , Adam J. Kole MD, PhD i, , Nitin Ohri MD j, , Salma K. Jabbour MD k, , Marcelo F. Di Carli MD l, , Paco Bravo MD m, , Joshua D. Mitchell MD, MSCI h n, , Benedicte Lefebvre MD a, , Nicholas S. Wilcox MD, MHSc a, , Kai Yi Wu MD a, , Jeffrey D. Bradley MD c d, , Steven J. Feigenberg MD c d, , Bonnie Ky MD, MSCE a b c Changes in Cardiac Function in Patients Receiving Radiation Therapy for Lung Cancer , Journal of Thoracic Oncology: 2026


Friedes C, Feigenberg S, Lefler D, Levin W, Naghavi A. Letter Regarding: RECIST Responses to Radiation in Retroperitoneal Soft Tissue Sarcoma: When and How Often Do They Occur? , J Surg Res., 324: 2026,304-306


Cole Friedes 1, Nikhil Yegya-Raman 2, Michelle Iocolano 2, William P Levin 2, Keith A Cengel 2, Jeffrey D Bradley 2, Steven J Feigenberg 2 Primary Tumor Failure After Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008 , Int J Radiat Oncol Biol Phys : 2026


Nikhil Yegya-Raman 1 2, Kyunga Ko 3 4 2, Ivy S Han 4, Joshua D Mitchell 5 6, Wei Zou 1 2, Nitin Ohri 7, Salma K Jabbour 8, Raymond H Mak 9, Clifford Robinson 6 10, William P Levin 1 2, Leanne Barrett 11, Congying Xia 4, Eva Berlin 1 2, Paco Bravo 12, Marcelo Di Carli 11, Roger Cohen 2, Sandra Hutton 5, Jonathan Keltz 7, Jessica Wang 4 2, Omotayo Fasan 4 2, Suneel N Nagda 1 2, Angie Seo 4, Amanda M Smith 4 2, Lova Sun 2, Michael Soike 13, Adam J Kole 13, Gerard Walls 10 14, Steven J Feigenberg 1 2, Bonnie Ky 3 4 2 Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study , Clin Transl Radiat Oncol .: 2026


Niema B Razavian 1, Alexis N Schutz 2, Leslie Chang 3, Valerie Guth 4, Srinath Sundararaman 5, Rojymon Jacob 6, Kathryn Huber 7, Steven J Feigenberg 8, Jaroslaw T Hepel 9 Results From the Practice Accreditation Resident Reviewer Program (PARRP) Pilot: Educating Radiation Oncology Residents About Practice Accreditation , Cureus : 2026


C. Friedes, … S.J. Feigenberg Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non–Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy , American Journal of Clinical Oncology : 2026


Steven Joel Feigenberg 1, Francesca Costabile 1, Ceylan Tanes 2, Kyle Bittinger 2, Roderick O'Connor 3, Divyansh Agarwal 4, Giorgos Skoufos 5, Silavano Salaris 6, Artemis Hatzigeorgiou 5, Nektarios Kostopoulos 1, Shane Lloyd 7, Cole Friedes 1, Lisha Chen 1, Nikhil Yegya-Raman 1, Keith Cengel 1, William Levin 1, Bakir Valentić 3, Tyler Quarton 8, Alexander A Shestov 9, Abigail Berman 10, Jeffrey Bradley 1, Amit Maity 7, Costantinos Koumenis 1, Edgar Ben-Josef 1, Andrea Facciabene 11 12 Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy , J Immunother Cancer: 2025